Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Rating of “Moderate Buy” by Analysts

Guardian Pharmacy Services, Inc. (NYSE:GRDN) has received a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $32.00.

A number of research firms have issued reports on GRDN. Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. Oppenheimer started coverage on shares of Guardian Pharmacy Services in a research report on Friday, October 10th. They issued an “outperform” rating and a $30.00 price objective for the company. Truist Financial raised their target price on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a research report on Friday, November 14th. Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Finally, Stephens increased their price target on Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a research note on Wednesday.

Guardian Pharmacy Services Price Performance

GRDN stock opened at $31.30 on Wednesday. The company’s 50 day simple moving average is $29.95 and its 200-day simple moving average is $26.34. Guardian Pharmacy Services has a 12 month low of $17.78 and a 12 month high of $37.43. The firm has a market capitalization of $1.98 billion, a PE ratio of 49.68 and a beta of 0.96.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Monday, November 10th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.01. The business had revenue of $377.43 million for the quarter, compared to the consensus estimate of $381.16 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 2.90%. As a group, sell-side analysts anticipate that Guardian Pharmacy Services will post 0.87 earnings per share for the current year.

Institutional Trading of Guardian Pharmacy Services

Hedge funds have recently added to or reduced their stakes in the business. Brown Advisory Inc. increased its position in shares of Guardian Pharmacy Services by 5.0% in the second quarter. Brown Advisory Inc. now owns 1,682,476 shares of the company’s stock worth $35,854,000 after acquiring an additional 79,652 shares in the last quarter. Wellington Management Group LLP boosted its position in Guardian Pharmacy Services by 3.3% during the 3rd quarter. Wellington Management Group LLP now owns 1,143,729 shares of the company’s stock worth $30,000,000 after purchasing an additional 36,072 shares during the period. Franklin Resources Inc. raised its position in Guardian Pharmacy Services by 8.2% in the third quarter. Franklin Resources Inc. now owns 1,056,240 shares of the company’s stock valued at $27,705,000 after purchasing an additional 80,033 shares during the period. Vanguard Group Inc. lifted its stake in shares of Guardian Pharmacy Services by 9.1% during the third quarter. Vanguard Group Inc. now owns 1,055,102 shares of the company’s stock worth $27,675,000 after purchasing an additional 88,296 shares in the last quarter. Finally, Boston Partners lifted its stake in shares of Guardian Pharmacy Services by 418.7% during the third quarter. Boston Partners now owns 1,046,877 shares of the company’s stock worth $26,922,000 after purchasing an additional 845,048 shares in the last quarter.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.